Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT02935283

Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders

Sponsor: Children's National Research Institute

View on ClinicalTrials.gov

Summary

In proximal urea cycle disorders (UCD), particularly ornithine transcarbamylase deficiency (OTCD), hyperammonemia (HA) causes increased brain glutamine (Gln) which perturbation is thought to be at the core of the neurological injury. In contrast, in distal UCD such as citrullinemia (argininosuccinate synthetase deficiency; (ASSD) and argininosuccinic aciduria (argininosuccinate lyase deficiency); (ASLD) cognitive impairment and neuropsychiatric disease are common even in the absence of acute HA. As a consequence, both citrulline and argininosuccinate (ASA) or their metabolic products have been implicated as neurotoxic. In this project the investigators will use state-of- the-art neuroimaging and neuropsychological methods to investigate whether patients with OTCD have chronically elevated brain Gln and reduced myo-inositol (mI) levels that correlate with regional brain structural abnormalities and neurocognitive dysfunction. The researchers will further investigate whether during an acute episode of HA elevated brain Gln and decreased mI levels correlate with the magnitude of cytotoxic edema and whether a Gln/mI ratio threshold can be identified at which the cytotoxic edema is followed by cell loss. Finally, the researchers will investigate whether regions of brain damage in ASSD and/or ASLD are distinct from those in OTCD and compare brain Gln levels in ASSD and ASLD in the absence of HA to those in OTCD. The investigators will also seek to determine if brain citrulline and ASA can be identified in the brains of patients with distal UCD and whether they correlate with brain abnormalities seen in MRI and neuropsychological testing. This project will elucidate the chronology of brain pathology both in acute hyperammonemia and chronic UCD and whether, proximal and distal UCD differ in their pathophysiology of brain damage.

Key Details

Gender

All

Age Range

7 Years - 50 Years

Study Type

OBSERVATIONAL

Enrollment

Start Date

2016-08

Completion Date

2025-12

Last Updated

2024-06-25

Healthy Volunteers

Yes

Conditions

Urea Cycle Disorders

Interventions

PROCEDURE

MRI

MRI, fMRI, 1H MRS, DTI

BEHAVIORAL

Behavioral

Battery of executive function tasks

Inclusion Criteria: Inclusion criteria for group 1: 1. Confirmed diagnosis of ornithine transcarbamylase deficiency (OTCD) by genetic analysis (genotype) and/or enzyme analysis with at least a single episode of HA hyperammonemic (HA) encephalopathy 2. Ability to undergo MRI without sedation 3. Ages 7 - 50 years 4. Ability to provide informed consent or assent to the procedures 5. Healthy controls (age and gender matched) Inclusion criteria for group 2: 1. Males and females with a UCD who are having an acute metabolic crisis, with ammonia levels between 100-300 µM 2. Subjects must be awake, and not comatose and able to maintain patent airway on their own and in the opinion of the examining physician, medically stable without risk for acute decompensation and must continue to be stable based on visual contact, vital sign measurement and voice contact with subjects while in the scanner 3. Age range 7-30 years 4. Able to undergo neuroimaging safely (i.e. without ferromagnetic devices) 5. Sexually active female of childbearing potential must agree to urine pregnancy test 6. Admitted to the hospital for treatment of HA at one of the 4 sites for this study 7. Can be subjects who were originally enrolled in aim 1 who then have HA (they will cross over to aim 2) Inclusion criteria for group 3 1. Confirmed diagnosis of arginosuccinate ASSD, and ASLD by genotype and/or enzyme analysis or healthy age and gender matched control 2. Ability to undergo MRI without sedation 3. Age 7 - 30 years 4. Able to provide informed consent or assent to the procedures Exclusion Criteria: Exclusion Criteria for group 1: 1. Inability to undergo MRI without sedation 2. Metal implants, including orthodontic braces 3. Other health conditions contra-indicated in MRI 4. Medically unstable at time of scheduled research visit 5. Unable to provide informed consent or assent to the procedures Exclusion criteria for group 2: 1. Ammonia level \> 300 µM, or \<100 µM 2. Presence of coma and/or inability to maintain a patent airway 3. Age \<7 or \>30 years 4. Subject with ferromagnetic device that precludes safe MRI imaging 5. Pregnant female 6. Unstable medically, at risk for decompensations 7. Combative, or severely neurologically compromised irrespective of ammonia level and showing declining medical status in the scanner based on visual, voice contact and electronic HR monitoring. Subjects must be awake, and not comatose and able to maintain patent airway on their own Exclusion criteria for group 3: 1. Inability to undergo MRI without sedation 2. Metal implants, including orthodontic braces 3. Other health conditions contra-indicated for MRI 4. Medically unstable at time of scheduled research visit 5. Unable to provide informed consent or assent

Locations (1)

Children's Research Institute

Washington D.C., District of Columbia, United States